Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

Protocol No
SWOG-S1802
Principal Investigator
Scott Johnson
Phase
III
Summary
This study is being done to answer the following question: Can we lower the chance of your prostate cancer growing or spreading by adding either prostate removal surgery or radiation therapy to the usual combination of drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for your prostate cancer. The usual approach is defined as care most people get for prostate cancer. The purpose of this study is to compare the effects, good and/or bad, of adding either prostate removal surgery or radiation therapy to standard systemic therapy (SST), which is used to treat prostate cancer. Standard systemic therapy includes Androgen Deprivation Therapy (ADT) with or without the use of chemotherapy. ADT is an antihormone therapy whose main use is in treating prostate cancer. The combination of SST and surgery or radiation therapy is considered experimental.
Description
Standard Systemic Therapy +/- Definitive Treatment in Treating Metastatic Prostate Cancer
Participating Institutions
Froedtert Menomonee Falls Hospital
Froedtert Hospital
Froedtert West Bend Hospital
Status
OPEN TO ACCRUAL
Share This: